Biological Therapy of Cancer - from basic research to clinical application
06/11/97-06/14/97
Program:
Phase I/II clinical trials, control of epithelial development, cytokine control of apoptosis, receptor binding and signal transduction,antibody therapy, vaccine therapy, gene therapy, targeted therapy, positive and negative control of haematopoiesis
Registration :
Dr Volkmar Nuessler (nuessler@gsf.de)
Deadline for Abstracts: 01/06/97
Email for Requests and Registration: nuessler@gsf.de